Enalapril and hydroxyurea therapy for children with sickle nephropathy

Pediatric Blood and Cancer

Volumn 45, Issue 7, 2005, Pages 982-985

  Fitzhugh, Courtney D ^a   Wigfall, Delbert R ^a   Ware, Russell E ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Enalapril; Hydroxyurea; Nephropathy; Proteinuria; Sickle cell anemia

Indexed keywords

ALBUMIN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HEMOGLOBIN F; HYDROXYUREA; POTASSIUM;

ADOLESCENT; ALBUMIN BLOOD LEVEL; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; CREATININE BLOOD LEVEL; FEMALE; HUMAN; KIDNEY DISEASE; MALE; NEPHROTIC SYNDROME; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY; SICKLE CELL ANEMIA; SICKLE NEPHROPATHY; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ALBUMINURIA; ANEMIA, SICKLE CELL; ANTIHYPERTENSIVE AGENTS; ANTISICKLING AGENTS; CHILD; CREATININE; DRUG EVALUATION; DRUG THERAPY, COMBINATION; ENALAPRIL; FEMALE; FETAL HEMOGLOBIN; HUMANS; HYDROXYUREA; KIDNEY FAILURE, CHRONIC; MALE; POTASSIUM; RETROSPECTIVE STUDIES; SERUM ALBUMIN;

EID: 27644533273     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20296     Document Type: Article

References (20)

1. Powars DR, Elliott-Mills DD, Chan L, et al. Chronic renal failure in sickle cell disease: Risk factors, clinical course, and mortality. Ann Int Med 1991;115:614-620.
2. Falk RJ, Jennette JC. Sickle cell nephropathy. Adv Nephrology 1994;23:133-147.
3. Pham PT, Pham PC, Wilkinson AH, et al. Renal abnormalities in sickle cell disease. Kidney International 2000;57:1-8.
4. Wesson DE. The initiation and progression of sickle cell nephropathy. Kidney International 2002;61:2277-2286.
5. Wigfall DR, Ware RE, Burchinal MR, et al. Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease. J Pediatr 2000;136:749-753.
6. Bakir AA, Hathiwala SC, Ainis H, et al. Prognosis of the nephrotic syndrome in sickle glomerulopathy: A retrospective study. Am J Nephrol 1987;7:110-115.
7. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-1644.
8. Abbott KC, Hypolite IO, Agodoa LY. Sickle cell nephropathy at end-stage renal disease in the United States: Patient characteristics and survival. Clin Nephrol 2002;58:9-15.
9. Ojo AO, Govaerts TC, Schmouder RL, et al. Renal transplantation in end-stage sickle cell nephropathy. Transplantation 1999;67:291-295.
10. Falk RJ, Scheinman J, Phillips G, et al. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med 1992;326:910-915.
11. Aoki RY, Saad STO. Enalapril reduces the albuminuria of patients with sickle cell disease. Am J Med 1995;98:432-435.
12. Foucan L, Bourhis V, Bangou J, et al. A randomized trial of captopril for microalbuminuria in normotensive adults with sickle cell anemia. Am J Med 1998;104:339-342.
13. Charache S. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995;332:1317-1322.
14. Kinney TR, Helms RW, O'Branski EE, et al. Safety of hydroxyurea in children with sickle cell anemia: Results of the HUG-KIDS study, a phase I/II trial. Blood 1999;94:1550-1554.
15. Zimmerman SA, Schultz WH, Davis JS, et al. Sustained long-term hematological efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. Blood 2004;103:2039-2045.
16. Ware RE, Zimmerman SA, Sylvestre PB, et al. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy. J Pediatr 2004;145:346-352.
17. Zimmerman SA, Mortier NA, Schultz WH, et al. Increased glomerular filtration rate as an early marker of sickle nephropathy in young children with sickle cell anemia (abstract). Am Soc Pediatr Hematol/Oncol 2004.
18. Dharnidharka WR, Dabbagh S, Atiyeh B, et al. Prevalence of microalbuminuria in children with sickle cell disease. Ped Nephrol 1998;12:475-478.
19. de Santis Feltran L, de Abreu Carvalhaes JT, Sesso R. Renal complications of sickle cell disease: Managing for optimal outcomes. Paed Drugs 2002;4:29-36.
20. Okpala I, Daniel Y, Haynes R, et al. Relationship between the clinical manifestations of sickle cell disease and the expression of adhesion molecules on white blood cells. Euro J Haem 2002;69:135-144.